×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| MEDICO REMEDIES LIMITED | 389.1 | 18.18 | 382.51 | 0.22 | 401.0 | 38.8 |
| BROOKS LABORATORIES LTD. | 257.29 | 26.51 | 255.12 | 0.9 | 399 | 197.0 |
| EVEREST ORGANICS LTD. | NA | NA | NA | NA | 392 | 63.1 |
MEDICO REMEDIES LIMITED, with Security Code 540937, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 28.0 | 31.5 | 42.4 | 29.8 | 41.3 | 30.8 | 39.3 | 39.5 | 41.3 | 38.3 |
| Expenses | 24.8 | 29.0 | 39.3 | 27.0 | 36.7 | 28.0 | 36.9 | 36.4 | 34.5 | 35.4 |
| Operating Profit | 3.2 | 2.5 | 3.1 | 2.7 | 4.6 | 2.8 | 2.4 | 3.1 | 6.8 | 2.8 |
| OPM % | 11.3% | 7.8% | 7.26% | 9.18% | 11.24% | 9.13% | 6.13% | 7.88% | 16.37% | 7.39% |
| Other Income | 0.0 | 0.3 | 1.0 | 0.3 | 0.6 | 0.3 | 0.7 | 1.4 | 0.3 | 0.7 |
| Interest | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.5 | 0.3 |
| Depreciation | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | 0.7 | 0.8 | 0.8 | 0.8 |
| Profit before tax | 2.3 | 1.9 | 3.1 | 2.1 | 4.2 | 2.2 | 2.1 | 3.5 | 5.8 | 2.4 |
| Tax % | -22.3% | -29.9% | -22.8% | -30% | -27% | -27.4% | -27.1% | -25.1% | -22.8% | 25.3% |
| Net Profit | 1.8 | 1.3 | 2.4 | 1.4 | 3.1 | 1.6 | 1.6 | 2.6 | 4.3 | 1.8 |
| EPS in Rs | 0.21 | 0.16 | 0.29 | 0.17 | 0.37 | 0.19 | 0.19 | 0.32 | 0 | 0.22 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 11% |
| 3 Years: | 8% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 44% |
| 3 Years: | 28% |
| TTM: | 22% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 71% |
| 3 Years: | 39% |
| 1 Year: | 41% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|